Literature DB >> 18303038

Health spending projections through 2017: the baby-boom generation is coming to Medicare.

Sean Keehan1, Andrea Sisko, Christopher Truffer, Sheila Smith, Cathy Cowan, John Poisal, M Kent Clemens.   

Abstract

The outlook for national health spending calls for continued steady growth. Spending growth is projected to be 6.7 percent in 2007, similar to its rate in 2006. Average annual growth over the projection period is expected to be 6.7 percent. Slower growth in private spending toward the end of the period is expected to be offset by stronger growth in public spending. The health share of gross domestic product (GDP) is expected to increase to 16.3 percent in 2007 and then rise throughout the projection period, reaching 19.5 percent of GDP by 2017.

Mesh:

Year:  2008        PMID: 18303038     DOI: 10.1377/hlthaff.27.2.w145

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  28 in total

1.  The impact of the patient-centered medical home on the biologics industry, employers, and third-party payers.

Authors:  John Greenwood; David B Nash
Journal:  Biotechnol Healthc       Date:  2009

2.  ASCO Addresses the Rising Cost of Cancer Care.

Authors:  Lowell E Schnipper; Neal Meropol
Journal:  J Oncol Pract       Date:  2009-07       Impact factor: 3.840

3.  Impact of generic substitution decision support on electronic prescribing behavior.

Authors:  Shane P Stenner; Qingxia Chen; Kevin B Johnson
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

4.  Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncology.

Authors:  Thomas Marsland; Gerald Robbins; Alan Marks; Robert Cassell; Dorothy Green Philips; Kristen King
Journal:  J Oncol Pract       Date:  2010-09       Impact factor: 3.840

5.  Sensitivity and specificity: imperfect predictors of guideline utility in radiology.

Authors:  B Roudsari; C McKinney; D Moore; J Jarvik
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

6.  Accuracy of annual prescription drug expenditure forecasts in AJHP.

Authors:  Patricia L Hartke; Lee C Vermeulen; James M Hoffman; Nilay D Shah; Fred Doloresco; Katie J Suda; Edward C Li; Linda M Matusiak; Robert J Hunkler; Glen T Schumock
Journal:  Am J Health Syst Pharm       Date:  2015-10-01       Impact factor: 2.637

7.  The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.

Authors:  Pamela Samson; Aalok Patel; Cliff G Robinson; Daniel Morgensztern; Su-Hsin Chang; Graham A Colditz; Saiama Waqar; Traves D Crabtree; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-08-25       Impact factor: 4.330

8.  Understanding patient perspectives on communication about the cost of cancer care: a review of the literature.

Authors:  Erin W Hofstatter
Journal:  J Oncol Pract       Date:  2010-06-22       Impact factor: 3.840

Review 9.  Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.

Authors:  A G Tsai; D F Williamson; H A Glick
Journal:  Obes Rev       Date:  2011-01       Impact factor: 9.213

Review 10.  Considerations for an obesity policy research agenda.

Authors:  Robin A McKinnon; C Tracy Orleans; Shiriki K Kumanyika; Debra Haire-Joshu; Susan M Krebs-Smith; Eric A Finkelstein; Kelly D Brownell; Joseph W Thompson; Rachel Ballard-Barbash
Journal:  Am J Prev Med       Date:  2009-02-11       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.